Compare Stocks: RVPH, SCLX, TXMD, and QNTM

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
QNTM Quantum Biopharma	$2.71 +1.9%	$3.36	$2.07 ▼ $15.50	$21.51M	0.39	207,783 shs	107,421 shs
RVPH Reviva Pharmaceuticals	$0.48 -0.7%	$0.50	$0.26 ▼ $15.40	$6.23M	0.48	316,622 shs	94,660 shs
SCLX Scilex	$2.82 -1.1%	$5.06	$2.77 ▼ $27.00	$24.20M	1.72	44,884 shs	12,497 shs
TXMD TherapeuticsMD	$1.93 -2.0%	$2.10	$1.03 ▼ $2.95	$22.80M	0.65	16,884 shs	17,989 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
QNTM Quantum Biopharma	-7.96%	-15.29%	-23.12%	-21.07%	-83.36%
RVPH Reviva Pharmaceuticals	-3.45%	-4.36%	-0.37%	-13.21%	-95.94%
SCLX Scilex	-1.04%	-18.34%	-44.12%	-67.58%	-80.45%
TXMD TherapeuticsMD	+0.51%	-1.50%	-8.80%	-3.43%	+89.42%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
QNTM Quantum Biopharma	$2.71 +1.9%	$3.36	$2.07 ▼ $15.50	$21.51M	0.39	207,783 shs	107,421 shs
RVPH Reviva Pharmaceuticals	$0.48 -0.7%	$0.50	$0.26 ▼ $15.40	$6.23M	0.48	316,622 shs	94,660 shs
SCLX Scilex	$2.82 -1.1%	$5.06	$2.77 ▼ $27.00	$24.20M	1.72	44,884 shs	12,497 shs
TXMD TherapeuticsMD	$1.93 -2.0%	$2.10	$1.03 ▼ $2.95	$22.80M	0.65	16,884 shs	17,989 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
QNTM Quantum Biopharma	-7.96%	-15.29%	-23.12%	-21.07%	-83.36%
RVPH Reviva Pharmaceuticals	-3.45%	-4.36%	-0.37%	-13.21%	-95.94%
SCLX Scilex	-1.04%	-18.34%	-44.12%	-67.58%	-80.45%
TXMD TherapeuticsMD	+0.51%	-1.50%	-8.80%	-3.43%	+89.42%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
QNTM Quantum Biopharma	2.00	Hold	$8.00	195.20% Upside
RVPH Reviva Pharmaceuticals	2.20	Hold	$53.33	11,128.07% Upside
SCLX Scilex	1.00	Sell	N/A	N/A
TXMD TherapeuticsMD	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest RVPH, SCLX, TXMD, and QNTM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/18/2026	SCLX Scilex	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
9/2/2026	SCLX Scilex	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
8/31/2026	QNTM Quantum Biopharma	Rodman & Renshaw Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$8.00
8/26/2026	TXMD TherapeuticsMD	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D+) ➝ Sell (D-)
8/21/2026	QNTM Quantum Biopharma	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
8/12/2026	TXMD TherapeuticsMD	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (D-) ➝ Sell (D+)

(Data available from 10/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
QNTM Quantum Biopharma	N/A	N/A	N/A	N/A	$1.34 per share	N/A
RVPH Reviva Pharmaceuticals	N/A	N/A	N/A	N/A	$1.48 per share	N/A
SCLX Scilex	$30.25M	0.79	N/A	N/A	($24.94) per share	-0.11
TXMD TherapeuticsMD	$3.02M	7.39	$0.05 per share	42.22	$2.32 per share	0.83

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
QNTM Quantum Biopharma	-$26.17M	-$5.49	N/A	N/A	N/A	N/A	-582.23%	-184.20%	11/6/2026 (Estimated)
RVPH Reviva Pharmaceuticals	-$19.86M	-$1.85	N/A	N/A	N/A	N/A	-391.58%	-119.08%	11/12/2026 (Estimated)
SCLX Scilex	-$358.73M	-$49.70	N/A	N/A	N/A	-1,414.57%	N/A	-147.00%	12/2/2026 (Estimated)
TXMD TherapeuticsMD	-$570K	$0.02	96.50	N/A	N/A	-6.64%	-1.09%	-0.78%	11/17/2026 (Estimated)

Latest RVPH, SCLX, TXMD, and QNTM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/12/2026	Q3 2026	RVPH Reviva Pharmaceuticals	-$0.29	N/A	N/A	N/A	N/A	N/A
11/6/2026	N/A	QNTM Quantum Biopharma	-$0.50	N/A	N/A	N/A	N/A	N/A
8/14/2026	Q2 2026	SCLX Scilex	-$0.1813	-$16.65	-$16.4687	-$16.65	$16.00 million	$7.64 million
8/13/2026	Q2 2026	QNTM Quantum Biopharma	-$0.4116	-$0.47	-$0.0584	-$0.47	N/A	N/A
8/13/2026	Q2 2026	RVPH Reviva Pharmaceuticals	-$0.3850	-$0.19	+$0.1950	N/A	N/A	N/A
8/11/2026	Q2 2026	TXMD TherapeuticsMD	-$6.1250	$0.01	+$6.1350	$0.01	$19.77 million	$0.87 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
QNTM Quantum Biopharma	N/A	N/A	N/A	N/A	N/A
RVPH Reviva Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
SCLX Scilex	N/A	N/A	N/A	N/A	N/A
TXMD TherapeuticsMD	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
QNTM Quantum Biopharma	N/A	1.20	1.19
RVPH Reviva Pharmaceuticals	N/A	2.08	2.08
SCLX Scilex	N/A	0.07	0.06
TXMD TherapeuticsMD	N/A	3.22	3.22

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
QNTM Quantum Biopharma	1.24%
RVPH Reviva Pharmaceuticals	63.18%
SCLX Scilex	69.67%
TXMD TherapeuticsMD	30.74%

Insider Ownership

Company	Insider Ownership
QNTM Quantum Biopharma	8.53%
RVPH Reviva Pharmaceuticals	8.90%
SCLX Scilex	4.50%
TXMD TherapeuticsMD	1.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
QNTM Quantum Biopharma	7	8.09 million	7.40 million	N/A
RVPH Reviva Pharmaceuticals	14	13.11 million	11.67 million	Optionable
SCLX Scilex	34	8.49 million	8.11 million	No Data
TXMD TherapeuticsMD	420	11.57 million	11.38 million	Optionable

RVPH, SCLX, TXMD, and QNTM Headlines

Recent News About These Companies

Contrasting TherapeuticsMD (NASDAQ:TXMD) and GSK (NYSE:GSK)

October 10, 2026 | americanbankingnews.com

Critical Comparison: Tilray Brands (NASDAQ:TLRY) & TherapeuticsMD (NASDAQ:TXMD)

October 5, 2026 | americanbankingnews.com

TherapeuticsMD (NASDAQ:TXMD) and Shineco (NASDAQ:SISI) Head to Head Analysis

October 5, 2026 | americanbankingnews.com

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors despite daily gains

June 5, 2026 | marketwatch.com

TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives

May 12, 2026 | tipranks.com

TherapeuticsMD Announces First Quarter 2026 Financial Results

May 12, 2026 | businesswire.com

TherapeuticsMD Inc. stock outperforms competitors on strong trading day

April 6, 2026 | marketwatch.com

TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy

April 2, 2026 | theglobeandmail.com

TherapeuticsMD Explains Brief Delay In Annual Filing

April 1, 2026 | tipranks.com

TherapeuticsMD Announces Full Year 2025 Financial Results

March 30, 2026 | finance.yahoo.com

TherapeuticsMD Announces Full Year 2025 Financial Results

March 30, 2026 | businesswire.com

TherapeuticsMD (NASDAQ:TXMD) Director Tommy Thompson Buys 8,400 Shares

December 30, 2025 | insidertrades.com

TherapeuticsMD approves key proposals at annual meeting

December 16, 2025 | msn.com

TherapeuticsMD: Q3 Earnings Snapshot

November 13, 2025 | timesunion.comT

TherapeuticsMD Reports Q3 2025 Financial Results

November 13, 2025 | msn.com

TherapeuticsMD Announces Third Quarter 2025 Financial Results

November 12, 2025 | businesswire.com

TherapeuticsMD Reports Q2 2025 Financial Results

August 12, 2025 | msn.com

TherapeuticsMD: Q2 Earnings Snapshot

August 12, 2025 | finance.yahoo.com

TherapeuticsMD Announces Second Quarter 2025 Financial Results

August 12, 2025 | businesswire.com

TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors despite daily gains

July 16, 2025 | marketwatch.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

RVPH, SCLX, TXMD, and QNTM Company Descriptions

Quantum Biopharma NASDAQ:QNTM

$2.71 +0.05 (+1.88%)

Closing price 04:00 PM Eastern

Extended Trading

$2.66 -0.05 (-1.85%)

As of 07:30 PM Eastern

Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Reviva Pharmaceuticals NASDAQ:RVPH

$0.48 0.00 (-0.67%)

As of 03:58 PM Eastern

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of various neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. Reviva Pharmaceuticals Holdings, Inc. was founded in 2018 and is headquartered in Cupertino, California.

Scilex NASDAQ:SCLX

$2.82 -0.03 (-1.05%)

Closing price 04:00 PM Eastern

Extended Trading

$2.82 0.00 (-0.18%)

As of 07:30 PM Eastern

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company is also developing three product candidates, including SP-102 (10 mg dexamethasone sodium phosphate viscous gel) (SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a Phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4% (SP-103), a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a Phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules) (SP-104), a novel low-dose delayed-release naltrexone hydrochloride, which has completed Phase 1 trials for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California.

TherapeuticsMD NASDAQ:TXMD

$1.93 -0.04 (-2.03%)

As of 04:00 PM Eastern

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RVPH, SCLX, TXMD, and QNTM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RVPH, SCLX, TXMD, and QNTM Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RVPH, SCLX, TXMD, and QNTM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

RVPH, SCLX, TXMD, and QNTM Company Descriptions

Quantum Biopharma NASDAQ:QNTM

Reviva Pharmaceuticals NASDAQ:RVPH

Scilex NASDAQ:SCLX

TherapeuticsMD NASDAQ:TXMD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RVPH, SCLX, TXMD, and QNTM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RVPH, SCLX, TXMD, and QNTM Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RVPH, SCLX, TXMD, and QNTM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

RVPH, SCLX, TXMD, and QNTM Company Descriptions

Quantum Biopharma NASDAQ:QNTM

Reviva Pharmaceuticals NASDAQ:RVPH

Scilex NASDAQ:SCLX

TherapeuticsMD NASDAQ:TXMD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools